SHARE
COPY LINK

COVID-19 VACCINES

Switzerland approves Moderna vaccine for teenagers

Switzerland has now approved both of its vaccines for use among people as young as 12.

Switzerland approves Moderna vaccine for teenagers
Photo by GUILLAUME SOUVANT / AFP

Switzerland on Monday approved Moderna’s Covid-19 vaccine for youngsters aged between 12 and 17 years old, weeks after EU regulators authorised the drug for the same age group.

The Swissmedic regulatory authority, which has already approved the Pfizer-BioNTech jab for over-12s, said results from an ongoing study showed Moderna had 93 percent efficacy in the young age group.

“The vaccine produced a similar immune response… in this study compared to young adults aged 18 to 25 years,” the regulator said.

Switzerland, which is not in the European Union, has its own regulatory process and was the first country in continental Europe to start using the Pfizer-BioNTech jab.

READ MORE: Switzerland to start Covid vaccinations for teenagers

The country has doled out more than 9.1 million doses and nearly 49.2 percent of the population of 8.6 million are now fully vaccinated. However, take-up has slowed in recent weeks. Nearly 2.5 million doses were administered in June but fewer than 1.4 million in July.

The virus has killed 10,354 people in Switzerland and 723,907 positive tests have been registered.

Moderna’s Covid-19 jab is used in 48 countries, behind AstraZeneca (161), Pfizer-BioNTech (88) and Sinopharm (49), according to an AFP count.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.
For members

COVID-19 VACCINES

Reader question: When will Switzerland authorise second Covid booster shots?

Even as other countries have started to administer fourth doses of a Covid-19 vaccine and the infections are on the rise again, Swiss health authorities still haven’t rolled out second boosters. This is why, and what lies ahead.

Reader question: When will Switzerland authorise second Covid booster shots?

As The Local reported on Tuesday, coronavirus is circulating again in Switzerland and rates of contamination are expected to soar in the coming weeks.

In fact, over a million people in Switzerland could catch the virus this summer.

 “More than 80,000 new contaminations per week” are expected in the next two months, according to Tanja Stadler, the former head of the Covid-19 Task Force — much more than during the past two summers, when the rate of infections slowed down.

READ MORE: ‘Over a million people’ in Switzerland could be infected with Covid this summer

Data from the Federal Office of Public Health (FOPH) indicates that the upward trend is already underway. The number of new reported cases has been soaring in the past few weeks — from below 10,000 a week in mid-April and beginning of May, to 24,704 new cases in the past seven days.

These are officially registered contaminations, but as “most of infected people will not be tested, the number of confirmed cases will be smaller on paper than in reality”, Stadler pointed out.

Although nearly all cases in Switzerland (99 percent) are caused by Omicron and its sub-variants, which are more contagious but less severe that the original Covid viruses, “more vulnerable people are likely to end up in hospital, and long Covid cases are also likely to rise”, she said.

What is FOPH’s official stance on second boosters?

Health authorities are currently recommending them only for people in high-risk categories — that is, those with a very weak immune system.

“There is no need for the general public to receive an additional booster vaccination in the current situation. According to available data, people who are fully vaccinated or vaccinated and cured are still well protected against severe forms of COVID-19”, FOPH said on May 23rd.

There has been no change in strategy since then, despite the increasing infection rates.

However, authorities relented on one point: they now allow fourth doses to be administered to people whose Covid certificates have expired but who plan to travel to countries where up-to-date immunisations are required.

FOPH said these travellers can get “off-label” shots — meaning being vaccinated before the official authorisation to do so is issued — but these doses will not be free of charge.

“The price will be set by the cantons and the vaccination centres”, FOPH said, adding, however, that “second boosters for people with weakened immune systems will remain free”.

Why are Swiss health authorities dragging their feet in authorising second boosters?

As with the original vaccine rollout at the beginning of 2021, which took longer here than elsewhere, Swiss slowness may be due to the abundance of caution. For instance, drugs regulator Swissmedic “took longer than many countries to approve new vaccines”.

This time around, FOPH is taking its time to examine benefits of second boosters for general population (as opposed to at-risk groups).

Part of it may be the uncertainty prevailing over the efficacy of vaccines, which were conceived to combat the original early strains like Delta, not the variants, and sub-variants, that emerged later.

“The current vaccine does not provide clear protection against the Omicron”, according to Giuseppe Pantaleo, head of the immunology unit at Vaud university hospital (CHUV).

So when will Switzerland authorise second boosters?

Health officials said they will issue official recommendations “before the summer holidays”, which means shortly.

Two scenarios are currently  foreseen by FOPH: “It may be that an additional booster vaccination is recommended only for people over 65 and those suffering from certain chronic diseases, but it is also possible that it will be intended for the entire population”.

READ MORE: UPDATE: When will Switzerland roll out second Covid boosters?

SHOW COMMENTS